First Mercantile Trust’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $170K | Sell |
6,370
-435
| -6% | -$11.6K | 0.02% | 470 |
|
|
2021
Q2 | $210K | Sell |
6,805
-378
| -5% | -$11.7K | 0.02% | 431 |
|
|
2021
Q1 | $188K | Buy |
+7,183
| New | +$188K | 0.02% | 458 |
|
|
2020
Q2 | – | Sell |
-2,468
| Closed | -$44K | – | 949 |
|
|
2020
Q1 | $44K | Buy |
2,468
+301
| +14% | +$5.37K | 0.01% | 723 |
|
|
2019
Q4 | $51K | Sell |
2,167
-6
| -0.3% | -$141 | 0.01% | 789 |
|
|
2019
Q3 | $60K | Buy |
2,173
+520
| +31% | +$14.4K | 0.01% | 791 |
|
|
2019
Q2 | $55K | Sell |
1,653
-12
| -0.7% | -$399 | 0.01% | 749 |
|
|
2019
Q1 | $58K | Buy |
1,665
+190
| +13% | +$6.62K | 0.01% | 761 |
|
|
2018
Q4 | $49K | Buy |
1,475
+275
| +23% | +$9.14K | 0.01% | 780 |
|
|
2018
Q3 | $60K | Buy |
+1,200
| New | +$60K | 0.01% | 770 |
|
|
2018
Q1 | – | Sell |
-5,864
| Closed | -$234K | – | 826 |
|
|
2017
Q4 | $234K | Sell |
5,864
-837
| -12% | -$33.4K | 0.05% | 493 |
|
|
2017
Q3 | $268K | Buy |
+6,701
| New | +$268K | 0.05% | 476 |
|
|
2015
Q4 | – | Sell |
-460
| Closed | -$6K | – | 977 |
|
|
2015
Q3 | $6K | Buy |
+460
| New | +$6K | ﹤0.01% | 958 |
|
|
2014
Q3 | – | Sell |
-4,380
| Closed | -$48K | – | 1202 |
|
|
2014
Q2 | $48K | Hold |
4,380
| – | – | ﹤0.01% | 960 |
|
|
2014
Q1 | $39K | Buy |
+4,380
| New | +$39K | ﹤0.01% | 1106 |
|